> People use your filrters in your Outook express (or other email client)
> under news
[quoted text clipped - 28 lines]
> Let us know, someone, if you download and try it, ok?
> j
I was wondering when I checked in on the group if it had moved to a
safer location a couple of weeks ago, by invite only somewhere?
Sad to see what one person can do across the whole of the group homes,
let alone what two or more can do :(
Zinn
>> On Dec 5, 12:53 am, J <russ...@ano.non> wrote: ironjustice <<
I wouldn't be listening to close to this .. 'j' .. thing ..
It was caught coldnuts stalking / anonymously following people from
groups to groups .. and the most recent .. attempting to .. infer ..
"he's treating and robbing the elderly in Calgary" ..
Can ANYONE believe that kind of .. proactiveness .. ?
It does have .. porphyria .. though .. which might explain it ..
IN SPITE of it's .. 'type' / questionable sanity .. I am .. STILL ..
"having more success in the medical field than anyone in history" ..
THAT is .. all .. that should .. matter .. in medical related
groups .. though ..
Isn't it ..
http://www.ceps.unh.edu/news/releases03/planalp1103.htm
------------------------------------------------------------
UNH Awarded Patent for Cancer Treatment
New kind of chemotherapy kills cancer cells
DURHAM, N.H. --DURHAM, N.H. - The University of New Hampshire (UNH)
has been granted a U.S. patent for a new way to kill cancer cells.
Roy Planalp, associate professor of chemistry in the UNH College of
Engineering and Physical Sciences, invented the novel chemotherapy in
collaboration with researchers at the National Institutes of Health
(NIH) and Wake Forest University Health Sciences in Winston-Salem,
N.C., which share the patent with UNH.
"This invention is exciting because it has significant potential for
cancer therapy," said Robert Dalton, director of the UNH Office of
Intellectual Property Management. "It also has potential for other
therapeutic areas as well."
Planalp and his collaborators, funded by a grant from NIH's National
Cancer Institute, found that they could kill cancer cells by starving
them of the essential nutrient iron. The treatment employs molecules
called chelators (KEE-late-ors), which bind tightly with metal. The
chelators that best bind iron are in the tachpyr family of substances
and are shaped like an open, six-fingered claw. They suck iron in and
then snap closed, like a spring-loaded trap.
"Iron is like money. It's an essential nutrient that's not always
bioavailable, so cells store iron and release it as needed," explained
Planalp. "What the chelators do is come in and rob the iron bank just
as the cell is making a withdrawal, so the cell makes another
withdrawal, and if there are more chelators, that gets robbed too.
This continues until the bank is empty and the cell can't function
anymore."
Encased by the chelator, the iron is no longer available to perform
its role in vital jobs like transporting oxygen, and the cancer cell
dies. The chelator, still holding tightly to the iron, is quickly
removed from the blood by the liver and expelled from the body. Side
effects are expected to be negligible as iron chelators are already
used to treat people with too much iron in their blood.
Planalp stumbled on the cancer-fighting potential of chelators while
experimenting with using them as diagnostic agents. While testing a
chelator bound to gallium, a metal that shows up well in CAT scans, he
found it discarded the gallium in favor of the iron needed by cells,
causing them to die. "We didn't expect this," said Planalp, "so we
decided to pursue it."
Animal testing at the NIH showed that iron chelators are effective at
killing several kinds of cancer cells and they are quickly removed by
the liver - too quickly, in fact. Planalp and his collaborators are
currently investigating ways to either keep iron chelators in the body
longer or speed them up so they can finish the job before they are
removed.
Chelators tailored to bind to toxic metals, such as mercury, chromium
or lead, may have other therapeutic applications. "It's all about
selectivity," said Planalp. "There's a whole set of challenges out
there for detoxification."
Awarded in July, the patent is now being marketed by Wake Forest to
companies which can turn the idea into a marketable product. Like
existing chemotherapy drugs, iron chelators will most likely be used
in a chemical "cocktail" containing other chemotherapy agents.
CAPTION
Spring-loaded trap: A drawing depticts a tachpyr molecule in its open
position, before it has bound with a metal, and in its closed
position, after it has sucked in the metal and trapped it.
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
> People use your filrters in your Outook express (or other email client)
> under news
[quoted text clipped - 28 lines]
> Let us know, someone, if you download and try it, ok?
> j